Role of treatment intensification in infants with acute lymphoblastic leukemia: results of two consecutive AIEOP studies.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Haematologica

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 16537119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia.

  2005cited by this paper
• Infant acute lymphoblastic leukemia with MLL gene rearrangements: outcome following intensive chemotherapy and hematopoietic stem cell transplantation.

  2004cited by this paper
• Improved outcome in high-risk childhood acute lymphoblastic leukemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II.

  2002cited by this paper
• New methodologic approaches for immunophenotyping acute leukemias.

  2001cited by this paper
• Biological and therapeutic aspects of infant leukemia.

  2000cited by this paper
• Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982–1995

  2000cited by this paper
• Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia.

  1999cited by this paper
• Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group.

  1999cited by this paper
• Intensified therapy for infants with acute lymphoblastic leukemia

  1998cited by this paper
• Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome.

  1998cited by this paper
• Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of slow early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: a report from the Children's Cancer Group.

  1997cited by this paper
• Infant Cancer in the U.S.: Histology‐Specific Incidence and Trends, 1973 to 1992

  1997cited by this paper
• Therapeutic trial for infant acute lymphoblastic leukemia: the Pediatric Oncology Group experience (POG 8493).

  1997influential reference
• Intensified therapy for infants with acute lymphoblastic leukemia

  1997cited by this paper
• Prognostic factors in the acute lymphoid and myeloid leukemias of infants.

  1996cited by this paper
• Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.

  1994cited by this paper
• Improved survival for acute lymphoblastic leukaemia in infancy: the experience of EORTC‐Childhood Leukaemia Cooperative Group

  1994cited by this paper
• Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Childrens Cancer Group phase III trial.

  1993influential reference
• Detection of ALL-1/AF4 fusion transcript by reverse transcription-polymerase chain reaction for diagnosis and monitoring of acute leukemias with the t(4;11) translocation.

  1993cited by this paper
• The immunophenotype in infant acute lymphoblastic leukaemia: correlation with clinical outcome. An Italian multicentre study (AIEOP)

  1992cited by this paper
• Acute lymphoblastic leukemia in infants less than one year of age: a cumulative experience of the Children's Cancer Study Group.

  1985cited by this paper
• as infants

  year unknowncited by this paper

• Clinical Outcomes of Acute Leukemia in Children Less Than 2 Years: Experience from a Tertiary Center in Thailand

  2025influential citation
• Pharmacokinetics of PEGasparaginase in Infants with Acute Lymphoblastic Leukemia

  2024cites this paper
• Prognostic significance of various 11q23/KMT2A rearrangements in infants with acute lymphoblastic leuekemia

  2021cites this paper
• The Outcome of Infants with Acute Lymphoblastic Leukemia Treated with Interfant-99 Protocol

  2021cites this paper
• Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia

  2018cites this paper
• Updates in the biology and therapy for infant acute lymphoblastic leukemia

  2017cites this paper
• Outcome of relapsed infant acute lymphoblastic leukemia treated on the interfant-99 protocol

  2017cites this paper
• [Infant acute leukemia].

  2016cites this paper
• Treatment outcome of young children with acute lymphoblastic leukaemia: achievements and directions implied from Shanghai Children's Medical Centre based SCMC‐ALL‐2005 protocol

  2015cites this paper
• The evolution of clinical trials for infant acute lymphoblastic leukemia

  2014cites this paper
• Rare childhood tumours: clinical challenges and genetic alterations

  2014cites this paper
• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.

  2014cites this paper
• Early use of allogeneic hematopoietic stem cell transplantation for infants with MLL gene-rearrangement-positive acute lymphoblastic leukemia

  2014cites this paper
• Interfant-99 protocol Outcome of congenital acute lymphoblastic leukemia treated on the

  2013cites this paper
• Acute lymphoblastic leukemia in infants: 20 years of experience.

  2013cites this paper
• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.

  2011cites this paper
• Allogeneic Hematopoietic Stem Cell Transplantation in Pediatric Acute Lymphoblastic Leukemia

  2010cites this paper
• Infant Acute Lymphoblastic Leukemia Rob Pieters

  2010influential citation
• ACUTE LYMPHOBLASTIC LEUKEMIA IN ADOLESCENTS AND YOUNG ADULTS IN FINLAND

  2010cites this paper
• Treatment including anthracyclines versus treatment not including anthracyclines for childhood cancer.

  2009cites this paper
• Outcome of congenital acute lymphoblastic leukemia treated on the Interfant-99 protocol.

  2009cites this paper
• Infant acute lymphoblastic leukemia: Lessons learned and future directions

  2009cites this paper
• Survival of children with cancer in Italy, 1989-98. A report from the hospital based registry of the Italian Association of Paediatric Haematology and Oncology (AIEOP).

  2008cites this paper
• The ABCs of infant leukemia.

  2008cites this paper
• nfant AML : The Highest Incidence n Infants

  2008cites this paper
• Clinical relevance of FLT3 gene abnormalities in Brazilian patients with infant leukemia

  2008cites this paper
• Treatment of pediatric acute lymphoblastic leukemia: Progress achieved and challenges remaining

  2007cites this paper
• Critical outcomes in critical Children ’ s Cancer Group ( CCG ) randomized trials : 1976 – 2004 Intervention Population More morbid Better

  2007cites this paper
• Acute lymphoblastic leukemia in infancy

  2007cites this paper
• A treatment protocol for infants younger than 1 year with acute lymphoblastic leukaemia (Interfant-99): an observational study and a multicentre randomised trial.

  2007cites this paper
• [On prognostic indicators in acute lymphoblastic leukemia in children].

  2006cites this paper
• En torno a los factores pronósticos en la leucemia linfoblástica aguda del niño

  2006influential citation